Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manson

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Biochemical and Biophysical Research Communications|October 24, 2007
Differential expression of erythroid genes in prion diseaseA R Brown, A R Alejo Blanco, G Miele, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challengesRegina Katzenschlager, Andrew Hughes, Andrew Evans, et al.
Genomics|December 1, 1994
Construction and characterization of a human chromosome 2-specific BAC libraryM Wang, X N Chen, S Shouse, et al.
International Journal of Obstetric Anesthesia|September 4, 2012
Maternal and preterm fetal sheep responses to dexmedetomidineK Uemura, K Shimazutsu, R J McClaine, et al.
Lupus Science & Medicine|November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulinJessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Frontiers in Immunology|March 14, 2022
Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experienceAsim Khan, Alice Cole, Naveen Bhadauria, et al.
Public Health in Practice (Oxford, England)|September 14, 2022
A rapid review and expert identification of the Allied Health Professions' interventions as a contribution to public health outcomesS Fowler Davis, L Farndon, D Harrop, et al.
The Lancet. Rheumatology|August 23, 2021
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case seriesLuke Flower, Nick Laundy, Maryam Khosravi, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Biochemical and Biophysical Research Communications|October 24, 2007
Differential expression of erythroid genes in prion diseaseA R Brown, A R Alejo Blanco, G Miele, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challengesRegina Katzenschlager, Andrew Hughes, Andrew Evans, et al.
Genomics|December 1, 1994
Construction and characterization of a human chromosome 2-specific BAC libraryM Wang, X N Chen, S Shouse, et al.
International Journal of Obstetric Anesthesia|September 4, 2012
Maternal and preterm fetal sheep responses to dexmedetomidineK Uemura, K Shimazutsu, R J McClaine, et al.
Lupus Science & Medicine|November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulinJessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Frontiers in Immunology|March 14, 2022
Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experienceAsim Khan, Alice Cole, Naveen Bhadauria, et al.
Public Health in Practice (Oxford, England)|September 14, 2022
A rapid review and expert identification of the Allied Health Professions' interventions as a contribution to public health outcomesS Fowler Davis, L Farndon, D Harrop, et al.
The Lancet. Rheumatology|August 23, 2021
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case seriesLuke Flower, Nick Laundy, Maryam Khosravi, et al.
Pageof 19